Abstract Trimethyltin (TMT), which has a variety of applications in industry and agricultural, is a neurotoxin that is known to affect the auditory system as well as central nervous system of humans and experimental animals. However, the mechanisms underlying TMT-induced auditory dysfunction are poorly understood. To gain insights into the neurotoxic effect of TMT on the peripheral auditory system, we treated cochlear organotypic cultures with concentrations of TMT ranging from 5 to 100 lM for 24 h. Interestingly, TMT preferentially damaged auditory nerve fibers and spiral ganglion neurons in a dose-dependent manner, but had no noticeable effects on the sensory hair cells at the doses employed. TMT-induced damage to auditory neurons was associated with significant soma shrinkage, nuclear condensation, and activation of caspase-3, biomarkers indicative of apoptotic cell death. Our findings show that TMT is exclusively neurotoxicity in rat cochlear organotypic culture and that TMT-induced auditory neuron death occurs through a caspase-mediated apoptotic pathway.
Introduction
Organotin compounds (OTCs) are wieldy used in industrial and agricultural settings as plastic stabilizers, pesticides, timber preservatives, and antifouling paints. Due to their widespread application during the past 50 years, a considerable amount of OTCs have been introduced into the environment (Hoch 2001) . As most of OTCs are toxic, these harmful contaminants pose great risk for human health and the ecosystem (Braman and Tompkins 1979; Cima 2011) . Among these potentially toxic compounds, trimethyltin (TMT) has received considerable attention as numerous studies have demonstrated it can act as a potent neurotoxin.
TMT is a trialkyl-tin compound that mainly damages the central nervous system (CNS) (Koczyk 1996) . TMT selectively induces neuronal death in the human and animal limbic system particularly in the hippocampus (Geloso et al. 2011a) . Humans occupationally exposed to TMT develop a limbic-cerebellar syndrome characterized by hearing loss, disorientation, amnesia, aggressive behavior, complex partial and tonic-clonic seizures, ataxia, and mild sensory neuropathy (Dorman 2000) . In experimental animals, TMT intoxication produces a similar syndrome with spontaneous-seizures, self-mutilation, vocalizations, hyperactivity, and aggressive behavior (Dyer et al. 1982) . A number studies with neural cell lines and primary cultures indicate that TMT exposure produces changes indicative of programmed cell death such as nuclear condensation, DNA fragmentation, membrane blebbing, and caspase activation Kuramoto et al. 2011; Mundy and Freudenrich 2006) . Similar neuronal pathologies were seen in vivo when TMT was given to rat and mice (Fiedorowicz et al. 2001; Morita et al. 2008) . Although the mechanisms underlying the neurotoxicity of TMT are still obscure, the damage induced by TMT in neurons is thought to involve several pathways such as oxidative stress, intracellular calcium overload, and mitochondrial damage (Aldridge et al. 1977; Ali et al. 1992; Misiti et al. 2008; Piacentini et al. 2008) . In addition, expression of stannin (Snn), a mitochondrial membrane protein mainly localized to cells with TMT sensitivity, appears to play an essential role in TMT-mediated selective neuronal degeneration (Davidson et al. 2004; Toggas et al. 1992) .
In addition to CNS injury, TMT can damage the peripheral auditory system (Chang and Dyer 1983b) . A single 4-6 mg/kg dose of TMT produced a frequency-dependent hearing loss that was most severe in the high frequency range (Eastman et al. 1987; Ruppert et al. 1984) . TMTinduced high frequency hearing loss was closely correlated with loss of the outer hair cells (OHC) in the basal turn of the cochlea (Crofton et al. 1990; Hoeffding and Fechter 1991) . Moderate doses of TMT induced hearing loss that but partially reversible; however, the recovery period measured by startle reflex audiometry was uncharacteristically prolonged (Young and Fechter 1986) . Apart from OHC loss, both the known neurotoxic effects and the acute disruption of compound action potential (CAP) by TMT suggest a possible mechanism involving direct injury to auditory neurons in addition to the OHC (Fechter and Liu 1995) . To evaluate the relative toxicities of TMT on neurons versus sensory hair cells (HC) within the cochlea, rat postnatal cochlear organotypic cultures were exposed to varying concentrations of TMT to assess the relative damage to auditory nerve fibers (ANF) and spiral ganglion neurons (SGN) compared OHC and inner hair cells (IHC).
Materials and Methods

Cochlear Organotypic Cultures
Postnatal day 3 (P3) SASCO Sprague-Dawley rats purchased from Charles River Laboratories were used for preparing cochlear organotypic cultures as described previously (Ding et al. 2011) . In brief, after rat pups were decapitated, the cochleae were quickly removed, and the whole basilar membrane containing the organ of Corti, ANF, and SGN was carefully dissected out and transferred on to rat tail collagen gel in a culture dish. Approximately, 10 ll of collagen gel (type I collagen gel 3.76 mg/ml in 0.02 N acetic acid, 109 basal medium eagle, 2 % sodium carbonate, at 9:1:1 ratio) was applied to the surface of a 35 9 10 mm culture dish and allowed to gel for about 30 min at room temperature. Afterward, 1.3 ml of serum-free medium (0.01 g/ml bovine serum albumin (Sigma A-4919), 1 % serum-free supplement (Sigma I-1884), 1 % 200 mM glutamate, 2.4 of 20 % glucose, 0.2 % penicillin G, 95.4 % 1X basal medium eagle (Sigma B-15220)) was added to the culture dish. The basilar membrane containing the sensory hair cells, SGN, and supporting cells was placed on the surface of the collagen gel and then maintained in an incubator at 37°C and 5 % CO 2 overnight. On the following day, fresh culture medium (2 ml) with or without various concentrations of TMT was added to each dish, and cochlear explants were cultured for an additional 24 h.
Trimethyltin Treatment
Cochleae were randomly divided into five groups (n = 10/group). One group served as normal control; the other four groups were treated with different concentrations of TMT. TMT stock solution was freshly prepared at a concentration of 10 mM in serum-free medium and diluted to a final concentration of 0 (control) 5, 10, 50, or 100 lM for each TMT-treated group. Explants were cultured in the incubator for 24 h and then harvested for histological analysis.
Immunohistochemical Staining
Cochlear explants were fixed with 10 % formalin for 2 h at 4°C and rinsed three times in 0.1 M phosphate-buffered saline (PBS). To stain neurofilaments, which are expressed in both type I and type II SGN and ANF as well as efferent fibers, specimens were immersed overnight at 4°C in a monoclonal primary mouse 200 kD anti-neurofilament antibody (Sigma, No142) diluted in 1 % Triton X-100 and 5 % goat serum in 0.1 M PBS (1:100). Specimens were rinsed three times with PBS and incubated for an additional 2 h at room temperature in a secondary goat anti-mouse antibody conjugated with Alexa Fluor488 (Life technologies, A11001) diluted in PBS (1:200). To stain hair cell stereocilia and cuticular plate, specimens were rinsed in PBS three times and incubated for 1 h at room temperature with Alexa Fluor 568-conjugated phalloidin (Life technologies, A12380) diluted in PBS (1:200). After rinsing in PBS, the specimens were immersed for 30 min in fresh To-Pro-3 solution (Life technologies, T3605, 1 mM in 0.75 ml DMSO diluted in 1 ml H 2 O) to label the nuclei of cells in the specimen. Specimens were subsequently mounted on glass slides in glycerin, coverslipped, and examined under a confocal microscope.
Cochleograms
Cochlear HC were observed and counted under a fluorescent microscope with the appropriate filter to visualize the stereocilia and cuticular plate of HC labeled with Alexa Fluor 568-conjugated phalloidin. The number of HC was counted over 0.24 mm intervals along the enter length of the basilar membrane from apex to base. Plots showing the percent IHC and OHC loss as a function of percent distance from the apex of the cochlea were used to construct cochleograms. Cochleograms for each treatment were averaged to generate a mean cochleogram using custom software (Dong et al. 2014; Wang et al. 2014 ).
Caspase-3 Staining
To evaluate caspase-3 activity in SGNs, cochlear explants in control and the 50 lM TMT group were labeled with a cell permeable fluorogenic caspase substrate, Red-VAD-FMK caspase, using a CaspGLOW Red Active Caspase Staining Kit (BioVision, K190) following the manufacturer instructions. Twelve hours after treatment, the unfixed specimens were incubated with Red-VAD-FMK caspase-3 diluted in culture medium (1:200) at 37°C and 5 % CO 2 for 60 min, and then rinsed three times with wash buffer and fixed in 10 % formalin for 2 h. To optimize contrast, the red fluorescence of activated caspase-3 was converted with software to green pseudo-color in the photomicrographs. Specimens were immunolabeled with an antibody against neurofilament 200 kD (see above), rinsed in PBS, mounted in glycerin on glass slides, and coverslipped.
Confocal Microscopy
Cochlear specimens were examined under a confocal microscope (Zeiss LSM-510 Meta) using appropriate filters to detect the green fluorescence of Alexa Fluor 488-labeled neurofilament (excitation 488 nm, emission 519 nm), red fluorescence of Alexa Fluor 568-labeled phalloidin (excitation 578 nm, emission 600 nm), purple fluorescence of ToPro-3-labeled nucleus (excitation 642 nm, emission 661 nm), and red fluorescence for caspase-3 (excitation 540 nm, emission 570 nm). As described previously, confocal images were processed using Confocal LSM Image Examiner and Adobe Photoshop CS 3.0 software as described previously Dong et al. 2014; Wang et al. 2014) .
Statistical Analysis
ANF and SGN counts were evaluated using a one-way analysis of variance (GraphPad Prism 5) and NewmanKeuls post hoc analysis as described below.
Results
TMT Damages ANF and SGN
To determine its neurotoxic effects on cochlear ANF, SGN, and HC, cochlear cultures were treated with 50 lM TMT for 24 h. Figure 1 illustrates the typical status of IHC and OHC, ANF and SGN from the upper middle turn of the cochlea in control cultures, and those treated with 50 lM TMT. In control cultures, the stereocilia bundle and cuticular plate of both the IHC and OHC were heavily labeled with phalloidin (red). The three rows of OHC and one row of IHC were arranged longitudinally in a gently curving arc; there was no sign of HC loss or damage. The peripheral ANF which project out radially to the HC from the SGN were intensely labeled with neurofilament 200 kD (green). The radial ANF were organized into smooth and thick fascicles. The SGN in normal control cultures had large, round, or oval-shaped soma with heavy neurofilament labeling of the cytoplasm and faint labeling of the nucleus (Fig. 1a) . Remarkably, in cultures treated with TMT for 24 h, the IHC and OHC maintained their normal structure and position; there was no obvious loss or damage to the HC. In contrast, TMT caused massive degenerative changes in the ANF and SGN (Fig. 1b) . After 24 h treatment with 50 lM TMT, most ANFs were fragmented and pixelated with nearly total loss of most peripheral fibers endings approaching the hair cells. The number of SGN was greatly reduced, and the soma of the remaining SGN was shrunken and condensed and the nucleus seldom visible.
Cochleograms
To evaluate the effect of TMT on cochlear HC, average cochleograms (n = 5/group) measuring the percentage of missing OHC and IHC as a function of percent distance from the apex of the cochlea were constructed after 24 h treatment with various concentrations of TMT. The mean loss of OHC and IHC for the control group (Fig. 1c) was \5 % along the basilar membrane except for the extreme base and apex of the cochlea; losses in these regions are mainly due to mechanical damage during cochlear dissection. Mean losses of OHC and IHC in the 5, 10, 50, and 100 lM groups were similar to the control group as illustrated in Fig. 1d for the 50 mM TMT dose. Mean cochleograms for all TMT doses were similar to Fig. 1d . HC loss did not increase with TMT dose and even at the highest concentration.
Dose-Dependent ANF Damage
Since neurofilaments are heavily expressed in neurons, our neurofilament antibody would be expected to label type I and type II ANF as well as efferent fibers. Since the vast majority of fibers innervating the cochlea are type I (90-95 %) or type II (5-10 %) afferents, our neurofilament labeling predominantly represents the effects of TMT on ANF (Brown and Ledwith 1990; Perkins and Morest 1975; Spoendlin and Gacek 1963) . Figure 2a -e shows the condition of ANF in the upper middle turn of the cochlea after 24 h in culture; data are shown for controls and those treated with varying concentrations of TMT. In control cultures, the ANF fascicles were thick and smooth (Fig. 2a) . However, in TMT-treated cultures, the ANF fascicles degenerated in a dose-dependent manner (Fig. 2b-e) . In cultures treated with 5 lM TMT, a slight decline in ANF density was evident, many blebs were present on the surviving fibers and fiber thickness had decreased. As TMT concentration increased, the numbers of surviving fibers decreased, the ANF fascicles became thinner and blebbing and fragmentation of ANF increased. At the highest TMT concentration, 100 lM, nearly all of the ANFs were absent and only the debris of ANF fascicles remained. However, a few intact fibers were still present at the highest concentration; these TMT-resistant fibers could conceivably represent type II fibers. Type II afferent fibers, which can be detected with an antibody against peripherin, tend to be resistant to trauma (Barclay et al. 2011; Lim 1976) .
Since TMT-induced damage to ANF was similar along the length of the cochlea, we quantified the numbers of surviving ANF in the upper middle turn of the cochlea; ANF were measured per 140-lm widths in control and TMT-treated samples. Figure 2f shows the mean numbers (n = 14/group) of ANF/140 lm in control cultures and cultures treated with various concentration of TMT. In control cultures, approximately 63 fibers were present per 140 lm. The mean numbers of ANF/140 lm decreased in a dose-dependent manner, and at 100 lM TMT, only 4.7 fibers were present per 140 lm. A one-way analysis of variance (ANOVA) showed there was a statistically significant effect of TMT treatment on ANF survival (oneway ANOVA, P \ 0.0001, F = 246.6). A Newman-Keuls post hoc test showed that the mean numbers of ANF in all comparison pairs were significantly different (NewmanKeuls post hoc analysis, P \ 0.05). Figure 3 illustrates the status of SGN in the upper middle turn of the cochlea of control cultures and cultures treated with TMT for 24 h. The SGN in control cultures had large and round or ovoid cell bodies; strong neurofilament 200 kD immunolabeling was present throughout the cytoplasm except for the nucleus (Fig. 3a) . However, in TMTtreated cultures, SGN soma size decreased with increasing TMT dose, and at the higher doses, the size of the nucleus was substantially smaller than normal (Fig. 3b-e) . After treatment with 100 lM TMT, nearly all SGNs were destroyed (Fig. 3e) .
Dose-Dependent SGN Degeneration
Since TMT-induced damage to SGN was similar along the length of the cochlea, we measured the density of SGN in the upper middle turn of the cochlea using procedures previously described (Wang et al. 2014) . Figure 3f shows the mean numbers (n = 10/group) of SGN per 10 5 lm 3 in control cultures and those treated with varying TMT concentrations. In control cultures, there were approximately 47 SGN per 10 5 lm 3 . However, in TMT-treated cultures, the mean numbers of SGN decreased in a dose-dependent manner so that at the 100 lM TMT dose there were *3 SGN per 10 5 lm 3 . There was a significant effect of TMT treatment on SGN survival (one-way ANOVA, P \ 0.0001, F = 74.68). SGN densities were also significantly different between the different TMT concentrations ( Fig. 3f ; Newman-Keuls post hoc analysis, P \ 0.05). Figure 4 illustrates the characteristic morphological features of SGN before and after TMT treatment. SGN were labeled with a neurofilament primary antibody and Alexa 488 secondary antibody (green). The nuclei of all cells were labeled with To-Pro-3; the normal blue fluorescence of To-Pro-3 was converted to red pseudo-color with software to enhance contrast. In control cultures, the SGN soma had a large round or ovoid shape (Fig. 4a) . The cytoplasm within the SGN was heavily labeled with neurofilament 200 kD, the round or ovoid-shaped nucleus in the center of the soma was heavily labeled by To-Pro-3, and ANF were labeled with neurofilament. However, in the TMT-treated cultures, SGN somas were greatly reduced in size with most neurites missing, and the SGN nuclei remarkably condensed (Fig. 4b) . To quantify the soma shrinkage, the cross-sectional area of SGN soma was measured as previously reported (Wei et al. 2010) . The histograms in Fig. 5a -e show the numbers of SGN versus soma size (n = 200 cells/group) in control cultures and cultures treated for 24 h with various concentrations of TMT. In controls, most SGN soma areas ranged from 150 to 250 lm 2 with the major peak located at 200 lm 2 . In the TMT-treated cultures, however, the distribution of SGN soma areas gradually shifted toward smaller values with increasing TMT dose. After treatment with 100 lM TMT, nearly all SGN had shrunken so that the major peak had decreased to 50 lm 2 . Figure 5f shows the mean size of SGN somas in control cultures and cultures treated with various TMT concentrations. TMT treatment caused a dose-dependent decrease in SGN soma size. Statistical analysis revealed a significant treatment effect (one-way ANOVA, P \ 0.0001, F = 198.4). The differences in SGN soma sizes between all compared groups were statistically significant (Newman-Keuls post hoc analysis, P \ 0.05).
TMT-Induced Morphological Changes
Caspase-3 Activation Induced by TMT
A fluorogenic probe was used to detect activated executioner caspase-3 in cochlear cultures. When the fluorogenic probe was left out of the culture, there was a complete absence of green caspase-3 labeling in the negative control (Fig. 3a) . When the fluorogenic probe was added to positive control cultures (Fig. 6b) , green caspase-3 labeling was present on some non-neuronal cells (negative for neurofilament 200 kD, dashed squares). However, a few shrunken SGN which stained positive for neurofilament and caspase-3 (circles, green/yellow) were detected. After 
Discussion
TMT is one of a several alkyltin derivatives that have a variety of industrial applications which include heat stabilizers in polyvinylchloride tubing, curing agents for rubber production, disinfectants in hospitals, and biocides. Human exposure to these compounds can result in a variety of clinical disorders resulting from damage or destruction of cells in the CNS, immune system, spleen, lung, and kidney (Brown et al. 1979; Geloso et al. 2011b; Philbert et al. 2000; Snoeij et al. 1985) . The distinct range of cellular targets of these compounds makes these toxins somewhat unique as they are structurally related though mechanistically function quite differently. Some of these differences can be attributed to divergences in their hydrophobicity which has the potential to control their toxic behavior (Komulainen and Bondy 1987; Mushak et al. 1982) . Differences in the affected targeted organs identified for each derivative imply that there are distinct biochemical pathways disrupted within these cells resulting in the toxic specificity. For example, TMT preferentially induces neuronal damage, whereas dimethyltin (DMT) induces myelin edema and astrocytes degeneration (O'Callaghan et al. 1989) . The reason for this is unclear as TMT exposure as well as other alkyltin derivatives can all provoke mitochondrial dysfunction and increase ROS, yet the final disrupted tissues are different (LeBel et al. 1990; Stine et al. 1988) . It has been suggested that the intrinsic discrepancy between susceptibility of neuronal and other cells to TMT may be dependent on differential regulation of the mitochondrial permeability transition pore (Qu et al. 2011) . The lack of TMT damage to postnatal HC may be related to the immature development of proteins, cellular organelles such mitochondria and aerobic respiration (Bruce et al. 2000; Ito et al. 1995; Weaver and Schweitzer 1994) . This hypothesis could be tested by applying TMT to more mature cochlear cultures. Another possibility is that Snn, a transmembrane protein that sensitizes cells to TMT damage, is not expressed in postnatal HC (Billingsley et al. 2006; Buck-Koehntop et al. 2005; Davidson et al. 2004; Toggas et al. 1992 ). This hypothesis could be evaluated by evaluating developmental changes in Snn expression in hair cells. A third possibility is that postnatal HC can be damaged by TMT, but only at higher doses or longer treatment durations than those employed in this study. This could be tested by using higher doses of TMT or applying TMT for longer durations. Although TMT toxicity has been extensively studied, characterization of the actual molecular processes and its intracellular targets has not been adequately described. In general, TMT toxicity results in apoptotic cell death, which includes chromatin condensation, nuclear fragmentation, mitochondrial dysfunction, ROS production, membrane blebbing, and caspase activation (Geloso et al. 2002; . TMT selectively destroyed neurons located in several brain areas including the neocortex, amygdala, and olfactory tubercle, although the most prominent effects were seen in the hippocampus (Balaban et al. 1988; Brown et al. 1979; Thompson et al. 1996) . Recent studies suggest that the highly conserved, 88-amino acid protein, Snn may mediate the selective toxicity of organotins (BuckKoehntop et al. 2005; Davidson et al. 2004; Toggas et al. 1992) . This is based on the observation that Snn predominates in tissues with high toxicity to TMT, which includes the CNS, immune system, spleen, kidney, and lung but is essentially lacking in cells that exhibit considerable resistance to TMT. Snn peptide has been shown to bind TMT in a 1:1 ratio and can dealkylate TMT to DMT (Davidson et al. 2004 ). Transfection of TMT-resistant NIH-3T3 mouse fibroblasts with Snn increased cytotoxicity to both TMT and DMT. The selective localization of Snn, along with its mitochondrial localization, coupled with its ability to bind and dealkylate TMT, suggests a possible mechanism by which alkyltin toxicity may be mediated.
In the context of hearing and the inner ear, TMT induces a permanent hearing loss and cochlear damage which is most pronounced at the high frequencies (Chang and Dyer 1983a; Eastman et al. 1987; Ruppert et al. 1984) . Consistent with this is the observation that OHC in the base of the cochlea appear to be sensitive to TMT toxicity (Crofton et al. 1990; Fechter and Liu 1995; Hoeffding and Fechter 1991) . Taken together, these results suggest that TMT is mainly toxic to HC in adult animals, although there is evidence that is also damages SGN (Chang and Dyer 1983b) . On the other hand, the acute effects of TMT in vivo indicate that it has limited effects on both the cochlear microphonic generated by the OHC, the endolymphatic potential generated by the stria vascularis, and the summating potential largely generated by IHC (Clerici et al. 1991; Durrant et al. 1998; Fechter and Liu 1994) . In contrast, TMT rapidly reduced the CAP. Since the CAP reflects the summed neural response from the auditory nerve, these results suggest that the acute effects of TMT predominantly damage the SGN consistent with our in vitro results. The large TMT-induced effects on the CAP occurred at a dose of 0.2 mg/kg, equivalent to 1.5 lM assuming a uniform distribution throughout the body (Fechter and Liu 1994) . This predicted dose is only slightly lower than the 5 lM TMT dose that caused a 30 % loss of SGN (Fig. 3f) . Given the obvious experimental differences (e.g., postnatal vs. adult, function vs. structure), the TMT anatomical damage seen in our cochlear cultures is in reasonable accord with the CAP data.
The TMT toxicity profile in the developing inner ear is largely unknown. Because of the known neurotoxic profile of TMT in the CNS, it is also reasonable to speculate that auditory neurons within the developing cochlea may, in fact, be a more sensitive target to this alkyltin derivative. To test this hypothesis, we used rat postnatal cochlear organotypic culture as a model system to determine the selective neurotoxic actions of TMT on the hair cells, supporting cells, and neurons in the cochlea. Our results clearly demonstrate that TMT preferentially destroys ANF and SGN in rat cochlear cultures in a dose-dependent manner. Qualitatively, damage to SGN and ANF appeared relatively uniform along the length of the cochlea; therefore, we quantified SGN and ANF losses in the middle of the cochlea. SGN and ANF degeneration occurred at concentrations as low as 5 lM after only 24 h treatment and nearly all the ANF and SGN were destroyed after 24 h treatment with 100 lM TMT. In contrast to prior studies in adult rats, there was little or no damage to either OHC or IHC even at the highest TMT concentration of 100 lM that destroyed virtually all SGN. This is not totally surprising as HC share some similarities with astrocytes, which contain the astrocytic marker, glial fibrillary acidic protein (GFAP) (Moriya et al. 1993) , and are less sensitive to TMT toxicity (Gunasekar et al. 2001) .
The mechanisms underlying the differences in TMT sensitivity between postnatal vs. adult SGN and HC are currently unknown. As noted above, similarities shared with astrocyte may promote the survival of HC relative to neurons after TMT exposure. Additionally, it has been demonstrated that hippocampal neurons containing the calcium-binding protein calretinin (CR) and parvalbumin (PV) are resistant to TMT-induced neuronal degeneration, whereas those containing calbindin (CB) are selectively damaged by TMT (Geloso et al. 1996 (Geloso et al. , 1997 . In contrast, both PV and CB-positive neurons are sensitive to TMT neurotoxicity, and only CR-positive neurons are resistant (Geloso et al. 1998; Reuhl et al. 1983 ). This, however, seems unlikely to account for this difference in the cochlea because CR and PV are also highly expressed by SGN (Dechesne et al. 1991; Soto-Prior et al. 1995) . Unfortunately, expression of Snn, identified as a critical factor in TMT-induced selective cytotoxicity in neurons in the CNS (Davidson et al. 2004; Reese et al. 2005) , has not been measured in the inner ear. Thus, further studies are needed to determine which cells in the cochlea express Snn and whether Snn expression changes during development.
Our data further demonstrate, for the first time, that TMT induces SGN cell death by apoptosis in cochlear cultures. TMT exposure caused significant morphological alterations in SGN characterized by soma shrinkage and nuclear condensation, morphological hallmarks of cells undergoing apoptosis. In addition, activation of caspase-3, a major executioner in the caspase-dependent apoptotic pathway, was also observed in the SGN during the early stage of TMT treatment, consistent with prior findings in CNS (Fiedorowicz et al. 2001; . TMT exposure has also been shown to enhance ROS formation leading to apoptotic cell death in a number of different cell lines and primary cultures (Wang et al. 2008; Zhang et al. 2006) . ROS production could damage mitochondria and activate an apoptotic pathway mediated by the activation of mitochondrial permeability transition pore, release of cytochrome c, and activation of effector caspase-3 (Qu et al. 2011) . Consistent with ROS involvement, TMT-induced neuronal apoptosis can be reduced by antioxidants that reduce ROS expression (Cookson et al. 1998; Qu et al. 2011; Shin et al. 2005 ).
Model of SGN Degeneration
Our results clearly demonstrated that TMT selectively destroys ANF and SGN in P3 cochlear organotypic cultures in a dose-dependent manner. Since there was no evidence of hair cell damage even at the highest dose employed, 100 lM, TMT could conceivably be used to develop several experimental models of selective SGN death. If TMT were applied to the round window of the postnatal cochlea, it could conceivably result in partial destruction of SGN with retention of OHC and IHC. In cases such as this, the cochlear amplification and sharp tuning provided by the OHC would remain intact, but the neural input to the CNS would be greatly reduced creating a model that could be used to examine the perceptual and electrophysiological consequences of sensory deprivation (Lobarinas et al. 2013) . Efforts are underway to use stem cells and trophic factors to regenerate SGN and their peripheral ANF (Diensthuber et al. 2014 ). The TMT model of selective SGN degeneration could conceivably be used as experimental platform to determine if and how stem cells form synaptic connections to HC in the organ of Corti and neurons in the cochlear nucleus. Efforts aimed at replenishing missing SGN are critical for the transmission of acoustic or electrical stimulation from the cochlea to the auditory brainstem (Bas et al. 2014; Berkingali et al. 2008; Schmiedt et al. 2002; Zhang et al. 2013 ).
Summary
Our results show that TMT selectively damages SGN and ANF in postnatal rat cochlear cultures without damaging the hair cells. Whether local application of TMT produces a similar pattern of damage in vivo in postnatal or adult cochlea remains an important unanswered question. TMT-induced auditory neuronal death occurs via a caspase-mediated apoptotic cell death pathway consistent with soma shrinkage and nuclear condensation, morphological hallmarks of programmed cell death. Further studies are required to determine the molecular mechanisms underlying the selective destruction of postnatal SGN and ANF in vitro and the reasons why postnatal HC are resistant to TMT. An important unanswered question is whether a development shift occurs in TMT toxicity such that HC become more vulnerable with advancing age due to neural myelination or developmental changes in the antioxidant enzymes expressed in HC and neurons.
